% https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1031083/Weekly_Flu_and_COVID-19_report_w44.pdf

\bibitem{Mensah2022}Mensah AA, Lacy J, Stowe J, Seghezzo G, Sachdeva R, Simmons R, Bukasa A, O'Boyle S, Andrews N, Ramsay M, Campbell H, Brown K. 2022. Disease severity during SARS-COV-2 reinfection: a nationwide study. \textit{J Infect} S0163-4453(22)00010-X

\bibitem{Salehi2021}Salehi-Vaziri M, Pouriayevali MH, Fotouhi F, Jalali T, Banifazl M, Farahmand B, Sadat Larijani M, Ahmadi Z, Fereydouni Z, Tavakoli M, Karami A, Azad-Manjiri S, Yektay Sanati P, Dahmardeh S, Nemati AH, Sajadi M, Kashanian S, Ramezani A. 2021. SARS-CoV-2 re-infection rate in Iranian COVID-19 cases within one-year follow-up. \textit{Microb Pathog} \textbf{161}(Pt B):105296

\bibitem{Mao2021}Mao Y, Wang W, Ma J, Wu S, Sun F. 2021. Reinfection rates among patients previously infected by SARS-CoV-2: systematic review and meta-analysis. \textit{Chin Med J (Engl)} \textbf{135}(2):145--152.

\bibitem{Malhotra2022}Malhotra S, Mani K, Lodha R, Bakhshi S, Mathur VP, Gupta P, Kedia S, Sankar J, Kumar P, Kumar A, Ahuja V, Sinha S, Guleria R; COVID Reinfection AIIMS Consortium, Dua A, Ahmad S, Sathiyamoorthy R, Sharma A, Sakya T, Gaur V, Chaudhary S, Sharma S, Madan D, Gupta A, Virmani S, Gupta A, Yadav N, Sachdeva S, Sharma S, Singh S, Pandey A, Singh M, Jhurani D, Sarkar S, Lokade AK, Mohammad A, Pandit S, Dubey R, Singh AK, Gohar N, Soni D, Bhattacharyya A, Rai S, Tummala S, Gupta I, Shukla S. 2022. SARS-CoV-2 Reinfection Rate and Estimated Effectiveness of the Inactivated Whole Virion Vaccine BBV152 Against Reinfection Among Health Care Workers in New Delhi, India. \textit{JAMA Netw Open} \textbf{5}(1):e2142210

\bibitem{Davies2021}Davies NG, Abbott S, Barnard RC, Jarvis CI, Kucharski AJ, Munday JD, Pearson CAB, Russell TW, Tully DC, Washburne AD, Wenseleers T, Gimma A, Waites W, Wong KLM, van Zandvoort K, Silverman JD; CMMID COVID-19 Working Group; COVID-19 Genomics UK (COG-UK) Consortium, Diaz-Ordaz K, Keogh R, Eggo RM, Funk S, Jit M, Atkins KE, Edmunds WJ. 2021. Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England. \textit{Science} \textbf{372}(6538):eabg3055

\bibitem{Collier2021}Collier DA, Ferreira IATM, Kotagiri P, Datir RP, Lim EY, Touizer E, Meng B, Abdullahi A; CITIID-NIHR BioResource COVID-19 Collaboration, Elmer A, Kingston N, Graves B, Le Gresley E, Caputo D, Bergamaschi L, Smith KGC, Bradley JR, Ceron-Gutierrez L, Cortes-Acevedo P, Barcenas-Morales G, Linterman MA, McCoy LE, Davis C, Thomson E, Lyons PA, McKinney E, Doffinger R, Wills M, Gupta RK. 2021. Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2. \textit{Nature} \textbf{596}(7872):417--422.

\bibitem{Bar-On2021}Bar-On YM, Goldberg Y, Mandel M, Bodenheimer O, Freedman L, Alroy-Preis S, Ash N, Huppert A, Milo R. 2021. Protection against Covid-19 by BNT162b2 Booster across Age Groups. 2021. \textit{N Engl J Med} \textbf{385}(26):2421--2430.

\bibitem{Cohn2022}Cohn BA, Cirillo PM, Murphy CC, Krigbaum NY, Wallace AW. 2022. SARS-CoV-2 vaccine protection and deaths among US veterans during 2021. \textit{Science} \textbf{375}(6578):331-336.


\bibitem{Mlcochova2021}Mlcochova P, Kemp SA, Dhar MS, Papa G, Meng B, Ferreira IATM, Datir R, Collier DA, Albecka A, Singh S, Pandey R, Brown J, Zhou J, Goonawardane N, Mishra S, Whittaker C, Mellan T, Marwal R, Datta M, Sengupta S, Ponnusamy K, Radhakrishnan VS, Abdullahi A, Charles O, Chattopadhyay P, Devi P, Caputo D, Peacock T, Wattal C, Goel N, Satwik A, Vaishya R, Agarwal M; Indian SARS-CoV-2 Genomics Consortium (INSACOG); Genotype to Phenotype Japan (G2P-Japan) Consortium; CITIID-NIHR BioResource COVID-19 Collaboration, Mavousian A, Lee JH, Bassi J, Silacci-Fegni C, Saliba C, Pinto D, Irie T, Yoshida I, Hamilton WL, Sato K, Bhatt S, Flaxman S, James LC, Corti D, Piccoli L, Barclay WS, Rakshit P, Agrawal A, Gupta RK. 2021. SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion. \textit{Nature} \textbf{599}(7883):114--119.

\bibitem{Kraemer2021}Kraemer MUG, Hill V, Ruis C, Dellicour S, Bajaj S, McCrone JT, Baele G, Parag KV, Battle AL, Gutierrez B, Jackson B, Colquhoun R, O'Toole A, Klein B, Vespignani A; COVID-19 Genomics UK (COG-UK) Consortium, Volz E, Faria NR, Aanensen DM, Loman NJ, du Plessis L, Cauchemez S, Rambaut A, Scarpino SV, Pybus OG. 2021. Spatiotemporal invasion dynamics of SARS-CoV-2 lineage B.1.1.7 emergence. 2021. \textit{Science} \textbf{373}(6557):889-895

\bibitem{Meng2022}Meng B, Abdullahi A, Ferreira IATM, Goonawardane N, Saito A, Kimura I, Yamasoba D, Gerber PP, Fatihi S, Rathore S, Zepeda SK, Papa G, Kemp SA, Ikeda T, Toyoda M, Tan TS, Kuramochi J, Mitsunaga S, Ueno T, Shirakawa K, Takaori-Kondo A, Brevini T, Mallery DL, Charles OJ; CITIID-NIHR BioResource COVID- Collaboration; Genotype to Phenotype Japan (GP-Japan) Consortium members; Ecuador-COVID19 Consortium, Bowen JE, Joshi A, Walls AC, Jackson L, Martin D, Smith KGC, Bradley J, Briggs JAG, Choi J, Madissoon E, Meyer K, Mlcochova P, Ceron-Gutierrez L, Doffinger R, Teichmann SA, Fisher AJ, Pizzuto MS, de Marco A, Corti D, Hosmillo M, Lee JH, James LC, Thukral L, Veesler D, Sigal A, Sampaziotis F, Goodfellow IG, Matheson NJ, Sato K, Gupta RK. 2022. Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts tropism and fusogenicity. \textit{Nature} doi: 10.1038/s41586-022-04474-x.

\bibitem{Hui2022}Hui KPY, Ho JCW, Cheung MC, Ng KC, Ching RHH, Lai KL, Kam TT, Gu H, Sit KY, Hsin MKY, Au TWK, Poon LLM, Peiris M, Nicholls JM, Chan MCW. 2022. SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo. \textit{Nature}  doi: 10.1038/s41586-022-04479-6.
 
\bibitem{Dejnirattisai2022}Dejnirattisai W, Huo J, Zhou D, Zahradník J, Supasa P, Liu C, Duyvesteyn HME, Ginn HM, Mentzer AJ, Tuekprakhon A, Nutalai R, Wang B, Dijokaite A, Khan S, Avinoam O, Bahar M, Skelly D, Adele S, Johnson SA, Amini A, Ritter TG, Mason C, Dold C, Pan D, Assadi S, Bellass A, Omo-Dare N, Koeckerling D, Flaxman A, Jenkin D, Aley PK, Voysey M, Costa Clemens SA, Naveca FG, Nascimento V, Nascimento F, Fernandes da Costa C, Resende PC, Pauvolid-Correa A, Siqueira MM, Baillie V, Serafin N, Kwatra G, Da Silva K, Madhi SA, Nunes MC, Malik T, Openshaw PJM, Baillie JK, Semple MG, Townsend AR, Huang KA, Tan TK, Carroll MW, Klenerman P, Barnes E, Dunachie SJ, Constantinides B, Webster H, Crook D, Pollard AJ, Lambe T; OPTIC Consortium; ISARIC4C Consortium, Paterson NG, Williams MA, Hall DR, Fry EE, Mongkolsapaya J, Ren J, Schreiber G, Stuart DI, Screaton GR. 2022. SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses. \textit{Cell} \textbf{185}(3):467-484.e15

\bibitem{Muik2022}Muik A, Lui BG, Wallisch AK, Bacher M, M\"uhl J, Reinholz J, Ozhelvaci O, Beckmann N, G\"uimil Garcia RC, Poran A, Shpyro S, Finlayson A, Cai H, Yang Q, Swanson KA, T\"ureci \"O, Sahin U. 2022. Neutralization of SARS-CoV-2 Omicron by BNT162b2 mRNA vaccine-elicited human sera. \textit{Science} \textbf{375}(6581):678-680

\bibitem{Altarawneh2022}Altarawneh H, Chemaitelly H, Tang P, Hasan MR, Qassim S, Ayoub HH, AlMukdad S, Yassine HM, Benslimane FM, Al Khatib HA, Coyle P, Al Kanaani Z, Al Kuwari E, Jeremijenko A, Hassan Kaleeckal A, Nizar Latif A, Mohammad Shaik R, Abdul Rahim HF, Nasrallah GK, Al Kuwari MG, Butt AA, Al Romaihi HE, Al-Thani MH, Al Khal A, Bertollini R, Abu-Raddad LJ.  2022. Protection afforded by prior infection against SARS-CoV-2 reinfection with the Omicron variant. \textit{medRxiv} 2022.01.05.22268782

\bibitem{Nunes2022}Nunes MC, Sibanda S, Baillie VL, Kwatra G, Aguas R, Madhi SA, the Wits VIDA HCW Study Group. 2022. SARS-CoV-2 Omicron symptomatic infections in previously infected or vaccinated South African healthcare workers. \textit{medRxiv} 2022.02.04.22270480

\bibitem{Lyngse2021}Lyngse FP, Mortensen LH, Denwood MJ, Christiansen LE, Moller CH, Skov RL, Spiess K, Fomsgaard A, Lassauni\`ere MM, Rasmussen M, Stegger M, Nielsen C, Sieber RN, Cohen AS, Moller FT, Overvad M, Molbak K, Krause TG, Kirkeby CT. 2021. SARS-CoV-2 Omicron VOC Transmission in Danish Households. \textit{medRxiv} 2021.12.27.21268278

\bibitem{Chivese221}Chivese T, Matizanadzo JT, Musa OAH, Hindy G, Furuya-Kanamori L, Islam N, Al-Shebly R, Shalaby R, Habibullah M, Al-Marwani T, Hourani RF, Nawaz AD, Haider MZ, Emara MM, Cyprian F, Doi SAR. 2021. The prevalence of adaptive immunity to COVID-19 and reinfection after recovery – a comprehensive systematic review and meta-analysis. \textit{medRxiv} 2021.09.03.21263103

\bibitem{Lacy2022}Lacy J, Mensah A, Simmons R, Andrews M, Siddiqui MR, Bukasa A, O'Boyle S, Campbell H, Brown K. 2022. Protective effect of a first SARS-CoV-2 infection from reinfection: a matched retrospective cohort study using PCR testing data in England. \textit{medRxiv} 2022.01.10.22268896;

Limited Cross-Variant Immunity after Infection with the SARS-CoV-2 Omicron Variant Without Vaccination
\bibitem{}Rahul K. Suryawanshi, Irene P Chen, Tongcui Ma, Abdullah M. Syed, Noah Brazer, Prachi Saldhi, Camille R Simoneau, Alison Ciling, Mir M. Khalid, Bharath Sreekumar, Pei-Yi Chen, G. Renuka Kumar, Mauricio Montano, Miguel A Garcia-Knight, Alicia Sotomayor-Gonzalez, Venice Servellita, Amelia Gliwa, Jenny Nguyen, Ines Silva, Bilal Milbes, Noah Kojima, Victoria Hess, Maria Shacreaw, Lauren Lopez, Matthew Brobeck, Fred Turner, Frank W Soveg, Ashley F. George, Xiaohui Fang, Mazharul Maishan, Michael Matthay, Warner C. Greene, Raul Andino, Lee Spraggon, Nadia R. Roan, Charles Y. Chiu, Jennifer Doudna, Melanie Ott
medRxiv 2022.01.13.22269243

\bibitem{McKeigue2021}McKeigue PM, McAllister DA, Robertson C, Stockton D, Colhoun HM, for the PHS COVID-19 Epidemiology and Research Cell. 2021. Reinfection with SARS-CoV-2: outcome, risk factors and vaccine efficacy in a Scottish cohort. \textit{medRxiv} 2021.11.23.21266574

\bibitem{Maier2021}Maier HE, Balmaseda A, Ojeda S, Cerpas C, Sanchez N, Plazaola M, van Bakel H, Kubale J, Lopez R, Saborio S, Barilla C, PSP Study Group, Harris E, Kuan G, Gordon A. 2021. An immune correlate of SARS-CoV-2 infection and severity of reinfections. \textit{medRxiv} 2021.11.23.21266767

\bibitem{Goldberg2021}Goldberg Y, Mandel M, Bar-On YM, Bodenheimer O, Freedman L, Ash N, Alroy-Preis S, Huppert A, Milo R. 2021. Protection and waning of natural and hybrid COVID-19 immunity. \textit{medRxiv} 2021.12.04.21267114

\bibitem{Chivese2021}Chivese T, Matizanadzo JT, Musa OAH, Hindy G, Furuya-Kanamori L, Islam N, Al-Shebly R, Shalaby R, Habibullah M, Al-Marwani T, Hourani RF, Nawaz AD, Haider MZ, Emara MM, Cyprian F, Doi SAR. 2021. The prevalence of adaptive immunity to COVID-19 and reinfection after recovery – a comprehensive systematic review and meta-analysis. \textit{medRxiv} 2021.09.03.21263103

\bibitem{Levin-Rector2021}Levin-Rector A, Firestein L, McGibbon E, Sell J, Lim S, Lee EH, Weiss D, Geevarughese A, Zucker JR, Greene SK. 2021. Reduced Odds of SARS-CoV-2 Reinfection after Vaccination among New York City Adults, June–August 2021. \textit{medRxiv} 2021.12.09.21267203

\bibitem{Mensah2021}Mensah AA, Campbell H, Stowe J, Seghezzo G, Simmons R, Lacy J, Bukasa A, O'Boyle S, Ramsay ME, Brown K, Ladhani S. 2021. Risk of SARS-CoV-2 reinfections in children: prospective national surveillance, January 2020 to July 2021, England. \textit{medRxiv} 2021.12.10.21267372
 
\bibitem{Abu-Raddad2021}Abu-Raddad LJ, Chemaitelly H, Bertollini R; National Study Group for COVID-19 Epidemiology. 2021. Severity of SARS-CoV-2 Reinfections as Compared with Primary Infections. \textit{N Engl J Med} NEJMc2108120

\bibitem{Bean2021}Bean DJ, Monroe J, Turcinovic J, Moreau Y, Connor JH, Sagar M. 2021. SARS-CoV-2 reinfection associates with unstable housing and occurs in the presence of antibodies. \textit{Clin Infect Dis} ciab940.

\bibitem{Pulliam2021}Pulliam JRC, van Schalkwyk C, Govender N, von Gottberg A, Cohen C, Groome MJ, Dushoff J, Mlisana K, Moultrie H. 2021. Increased risk of SARS-CoV-2 reinfection associated with emergence of the Omicron variant in South Africa. \textit{medRxiv} 2021.11.11.21266068

\bibitem{Naveca2021}Naveca FG, Nascimento VA, Nascimento F, Ogrzewalska M, Pauvolid-Corr\^ea A, Araujo MF, Arantes I, Batista \'ELR, Magalh\~aes AL\'A, Vinhal F, Mattos TP, Riediger I, do Carmo Debur M, Grinsztejn B, Veloso VG, Brasil P, Rodrigues RR, Rovaris DB, Fernandes SB, Fernandes C, Santos JHA, Abdalla LF, Costa-Filho R, Silva M, Souza V, Costa \'AA, Mej\'ia M, Brand\~ao MJ, Goncalves LF, Silva GA, de Jesus MS, Pessoa K, de Lima Guerra Corado A, Duarte DCG, Machado AB, de Azevedo Zukeram K, Valente N, Lopes RS, Pereira EC, Appolinario LR, Rocha AS, Tort LFL, Sekizuka T, Itokawa K, Hashino M, Kuroda M, Wallau GL, Delatorre E, Gr\"af T, Siqueira MM, Bello G, Resende PC. 2021. A case series of SARS-CoV-2 reinfections caused by the variant of concern Gamma in Brazil. \textit{medRxiv} 2021.11.29.21266109

\bibitem{GISAID}Shu Y, McCauley J. 2017. GISAID: Global initiative on sharing all influenza data - from vision to reality. \textit{Euro Surveill} \textbf{22}(13):30494

\bibitem{McIntosh1967PNAS}McIntosh K, Dees JH, Becker WB, Kapikian AZ, Chanock RM. 1967. Recovery in tracheal organ cultures of novel viruses from patients with respiratory disease. \textit{Proc Natl Acad Sci USA} \textbf{57}:933--940.

\bibitem{Shastri2021}Shastri J, Parikh S, Aggarwal V, Agrawal S, Chatterjee N, Shah R, Devi P, Mehta P, Pandey R. 2021. Severe SARS-CoV-2 Breakthrough Reinfection With Delta Variant After Recovery From Breakthrough Infection by Alpha Variant in a Fully Vaccinated Health Worker. \textit{Front Med (Lausanne)} \textbf{8}:737007

\bibitem{Hasanzadeh2021}Hasanzadeh S, Shariatmaghani SS, Vakilian A, Javan A, Rahmani M, Ganjloo S, Jangi M, Amel Jamehdar S. 2021. Case series: Reinfection of recovered SARS CoV-2 patients for the third time. \textit{Clin Case Rep} \textbf{9}(10):e04936

\bibitem{McIntosh1967OC43}McIntosh K, Becker WB, Chanock RM. 1967. Growth in suckling-mouse brain of ``IBV-like'' viruses from patients with upper respiratory tract disease. \textit{Proc Natl Acad Sci U S A} \textbf{58}(6):2268--2273

\bibitem{McIntosh1967}McIntosh K, Dees JH, Becker WB, Kapikian AZ, Chanock RM. 1967. Recovery in tracheal organ cultures of novel viruses from patients with respiratory disease.. \textit{Proc Natl Acad Sci U S A} \textbf{57}(4):933--940.

\bibitem{deVrieze2020}de Vrieze J. 2020. Reinfections, still rare, provide clues on immunity. \textit{Science} \textbf{370}(6519):895--897.

\bibitem{Hamre1966}Hamre D, Procknow JJ. 1966. A new virus isolated from the human respiratory tract. \textit{Proc Soc Exp Biol Med} \textbf{121}(1):190--193

\bibitem{Fouchier2004}Fouchier RA, Hartwig NG, Bestebroer TM, Niemeyer B, de Jong JC, Simon JH, Osterhaus AD.. 2004. A previously undescribed coronavirus associated with respiratory disease in humans. \textit{Proc Natl Acad Sci U S A} \textbf{101}(16):6212--6216

\bibitem{Pyrc2004}Pyrc K, Jebbink MF, Berkhout B, van der Hoek L. 2004. Genome structure and transcriptional regulation of human coronavirus NL63. \textit{Virol J} \textbf{1}:7

\bibitem{Woo2006}Woo PC, Lau SK, Chu CM, Chan KH, Tsoi HW, Huang Y, Wong BH, Poon RW, Cai JJ, Luk WK, Poon LL, Wong SS, Guan Y, Peiris JS, Yuen KY. 2005. Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia. \textit{J Virol} \textbf{79}(2):884--895

\bibitem{Lau2006}Lau SK, Woo PC, Yip CC, Tse H, Tsoi HW, Cheng VC, Lee P, Tang BS, Cheung CH, Lee RA, So LY, Lau YL, Chan KH, Yuen KY. 2006. Coronavirus HKU1 and other coronavirus infections in Hong Kong. \textit{J Clin Microbiol} \textbf{44}(6):2063--2071

\bibitem{Vabret2006}Vabret A, Dina J, Gouarin S, Petitjean J, Corbet S, Freymuth F. 2006. Detection of the new human coronavirus HKU1: a report of 6 cases. \textit{Clin Infect Dis} \textbf{42}(5):634--639

\bibitem{Arafkas2021}Arafkas M, Khosrawipour T, Kocbach P, Zielinski K, Schubert J, Mikolajczyk A, Celinska M, Khosrawipour V. 2021. Current meta-analysis does not support the possibility of COVID-19 reinfections. \textit{J Med Virol} \textbf{93}(3):1599--1604.

\bibitem{Ledford2020}Ledford H. 2020. Coronavirus reinfections: three questions scientists are asking. \textit{Nature} \textbf{585}(7824):168--169.

\bibitem{JabbariRezaei2020}Jabbari P, Rezaei N. 2020. With Risk of Reinfection, Is COVID-19 Here to Stay? \textit{Disaster Med Public Health Prep} \textbf{14}(4):e33

\bibitem{Duggan2021}Duggan NM, Ludy SM, Shannon BC, Reisner AT, Wilcox SR. 2021. Is novel coronavirus 2019 reinfection possible? Interpreting dynamic SARS-CoV-2 test results. \textit{Am J Emerg Med} \textbf{39}:256.e1-256.e3.

\bibitem{YorkA2020}York A. 2020. Can COVID-19 strike twice? \textit{Nat Rev Microbiol} \textbf{18}(9):477.

\bibitem{Law2020}Law SK, Leung AWN, Xu C. 2020. Is reinfection possible after recovery from COVID-19? \textit{Hong Kong Med J} \textbf{26}(3):264--265.

\bibitem{Shinde2021}Shinde V, Bhikha S, Hoosain Z, Archary M, Bhorat Q, Fairlie L, Lalloo U, Masilela MSL, Moodley D, Hanley S, Fouche L, Louw C, Tameris M, Singh N, Goga A, Dheda K, Grobbelaar C, Kruger G, Carrim-Ganey N, Baillie V, de Oliveira T, Lombard Koen A, Lombaard JJ, Mngqibisa R, Bhorat AE, Benad\'e G, Lalloo N, Pitsi A, Vollgraaff PL, Luabeya A, Esmail A, Petrick FG, Oommen-Jose A, Foulkes S, Ahmed K, Thombrayil A, Fries L, Cloney-Clark S, Zhu M, Bennett C, Albert G, Faust E, Plested JS, Robertson A, Neal S, Cho I, Glenn GM, Dubovsky F, Madhi SA; 2019nCoV-501 Study Group. 2021. Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant. \textit{N Engl J Med} \textbf{384}(20):1899--1909.

\bibitem{Rangachev2021}Rangachev A, Marinov GK, Mladenov M. 2021. The demographic and geographic impact of the COVID pandemic in Bulgaria and Eastern Europe in 2020. \textit{medRxiv} 2021.04.06.21254958

\bibitem{Wang2020}Wang C, Horby PW, Hayden FG, Gao GF. 2020. A novel coronavirus outbreak of global health concern. \textit{Lancet} \textbf{395}(10223):470--473. 

\bibitem{Zhou2020}Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Si HR, Zhu Y, Li B, Huang CL, Chen HD, Chen J, Luo Y, Guo H, Jiang RD, Liu MQ, Chen Y, Shen XR, Wang X, Zheng XS, Zhao K, Chen QJ, Deng F, Liu LL, Yan B, Zhan FX, Wang YY, Xiao GF, Shi ZL. 2020. A pneumonia outbreak associated with a new coronavirus of probable bat origin. \textit{Nature} \textbf{579}(7798):270--273.

\bibitem{Huang2020}Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. 2020. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. \textit{Lancet} \textbf{395}(10223):497--506. 

\bibitem{Wat2004}Wat D. 2004. The common cold: a review of the literature. \textit{Eur J Intern Med} \textbf{15}(2):79--88

\bibitem{Makela1998}M\"akel\"a MJ, Puhakka T, Ruuskanen O, Leinonen M, Saikku P, Kimpim\"aki M, Blomqvist S, Hyypiä T, Arstila P. 1998. Viruses and bacteria in the etiology of the common cold. \textit{J Clin Microbiol} \textbf{36}(2):539--542.

\bibitem{Larson1980}Larson HE, Reed SE, Tyrrell DA. 1980. Isolation of rhinoviruses and coronaviruses from 38 colds in adults. \textit{J Med Virol} \textbf{5}(3):221--29

\bibitem{Nicholson1997}Nicholson KG, Kent J, Hammersley V, Cancio E. 1997. Acute viral infections of upper respiratory tract in elderly people living in the community: comparative, prospective, population based study of disease burden. \textit{BMJ} \textbf{315}(7115):1060--1064

\bibitem{Yewdell2021}Yewdell JW. 2021. Individuals cannot rely on COVID-19 herd immunity: Durable immunity to viral disease is limited to viruses with obligate viremic spread. \textit{PLoS Pathog} \textbf{17}(4):e100950

\bibitem{Callow1990}Callow KA, Parry HF, Sergeant M, Tyrrell DA. 1990. The time course of the immune response to experimental coronavirus infection of man. \textit{Epidemiol Infect} \textbf{105}:435--446.

\bibitem{Monto1974}Monto AS. Medical reviews: coronaviruses. \textit{Yale J Biol Med} \textbf{47}:234--251.

\bibitem{KahnMcIntosh2005}Kahn JS, McIntosh K. 2005. History and recent advances in coronavirus discovery. \textit{Pediatr Infect Dis J} \textbf{24}(11 Suppl):S223--227.

% \bibitem{SmithJ2020}Smith J. 2020. South Korea reports more recovered coronavirus patients testing positive again: Reuters; 2020. Available online at:  \burl{https://www.reuters.com/article/us-health-coronavirus-southkorea/south-korea-reports-more-recovered-coronavirus-patients-testing-positive-again-idUSKCN21V0JQ}

\bibitem{Mahase2020}Mahase E. 2020. Covid-19: WHO and South Korea investigate reconfirmed cases. \textit{BMJ} \textbf{369}:m1498

\bibitem{Tang2021}Tang CY, Wang Y, McElroy JA, Li T, Hammer R, Ritter D, Lidl GM, Webby R, Hang J, Wan XF. 2021. Reinfection with two genetically distinct SARS-CoV-2 viruses within 19 days. \textit{J Med Virol} \textbf{93}(10):5700--5703.

\bibitem{LeeJS2020}Lee JS, Kim SY, Kim TS, Hong KH, Ryoo NH, Lee J, Park JH, Cho SI, Kim MJ, Kim YG, Kim B, Shin HS, Oh HS, Seo MS, Gwon TR, Kim Y, Park JS, Chin BS, Park WB, Park SS, Seong MW. 2020. Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection After Recovery from Mild Coronavirus Disease 2019. \textit{Clin Infect Dis} ciaa1421.

\bibitem{Mulder2020}Mulder M, van der Vegt DSJM, Oude Munnink BB, GeurtsvanKessel CH, van de Bovenkamp J, Sikkema RS, Jacobs EMG, Koopmans MPG, Wegdam-Blans MCA. 2020. Reinfection of SARS-CoV-2 in an immunocompromised patient: a case report. \textit{Clin Infect Dis} ciaa1538

\bibitem{ToKK2020}To KK, Hung IF, Ip JD, Chu AW, Chan WM, Tam AR, Fong CH, Yuan S, Tsoi HW, Ng AC, Lee LL, Wan P, Tso E, To WK, Tsang D, Chan KH, Huang JD, Kok KH, Cheng VC, Yuen KY. 2020. COVID-19 re-infection by a phylogenetically distinct SARS-coronavirus-2 strain confirmed by whole genome sequencing. \textit{Clin Infect Dis} ciaa1275

\bibitem{LarsonD2020}Larson D, Brodniak SL, Voegtly LJ, Cer RZ, Glang LA, Malagon FJ, Long KA, Potocki R, Smith DR, Lanteri C, Burgess T, Bishop-Lilly KA. 2020. A Case of Early Re-infection with SARS-CoV-2. \textit{Clin Infect Dis} ciaa1436

\bibitem{GoldmanJD2020}Goldman JD, Wang K, Roltgen K, Nielsen SCA, Roach JC, Naccache SN, Yang F, Wirz OF, Yost KE, Lee JY, Chun K, Wrin T, Petropoulos CJ, Lee I, Fallen S, Manner PM, Wallick JA, Algren HA, Murray KM, Su Y, Hadlock J, Jeharajah J, Berrington WR, Pappas GP, Nyatsatsang ST, Greninger AL, Satpathy AT, Pauk JS, Boyd SD, Heath JR. 2020. Reinfection with SARS-CoV-2 and Failure of Humoral Immunity: a case report. \textit{medRxiv} 2020.09.22.20192443

\bibitem{Prado-Vivar2021}Prado-Vivar B, Becerra-Wong M, Guadalupe JJ, M\'arquez S, Gutierrez B, Rojas-Silva P, Grunauer M, Trueba G, Barragán V, Cárdenas P. 2021. A case of SARS-CoV-2 reinfection in Ecuador. \textit{Lancet Infect Dis} \textbf{21}(6):e142.

\bibitem{Sevillano2021}Sevillano G, Ortega-Paredes D, Loaiza K, Zurita-Salinas C, Zurita J. 2021. Evidence of SARS-CoV-2 reinfection within the same clade in Ecuador: A case study. \textit{Int J Infect Dis} \textbf{108}:53--56.

\bibitem{Karlinsky2021}Karlinsky A, Kobak D. 2021. Tracking excess mortality across countries during the COVID-19 pandemic with the World Mortality Dataset. \textit{Elife} \textbf{10}:e69336

\bibitem{GuptaV2020}Gupta V, Bhoyar RC, Jain A, Srivastava S, Upadhayay R, Imran M, Jolly B, Divakar MK, Sharma D, Sehgal P, Ranjan G, Gupta R, Scaria V, Sivasubbu S. 2020. Asymptomatic reinfection in two healthcare workers from India with genetically distinct SARS-CoV-2. \textit{Clin Infect Dis} ciaa1451

\bibitem{Shastri2021}Shastri J, Parikh S, Agrawal S, Chatterjee N, Pathak M, Chaudhary S, Sharma C, Kanakan A, A V, Srinivasa Vasudevan J, Maurya R, Fatihi S, Thukral L, Agrawal A, Pinto L, Pandey R, Sunil S. 2021. Clinical, Serological, Whole Genome Sequence Analyses to Confirm SARS-CoV-2 Reinfection in Patients From Mumbai, India. \textit{Front Med (Lausanne)} \textbf{8}:631769

\bibitem{Resende2021}Resende PC, Bezerra JF, Teixeira Vasconcelos RH, Arantes I, Appolinario L, Mendonça AC, Paixao AC, Duarte AC, Silva T, Rocha AS, Lima ABM, Pauvolid-Corrêa A, Motta FC, Teixeira DLF, de Oliveira Carneiro TF, Neto FPF, Herbster ID, Leite AB, Riediger IN, do Carmo Debur M, Naveca FG, Almeida W, Livorati M, Bello G, Siqueira MM. 2021. Severe Acute Respiratory Syndrome Coronavirus 2 P.2 Lineage Associated with Reinfection Case, Brazil, June-October 2020. \textit{Emerg Infect Dis} \textbf{27}(7):1789--1794.

\bibitem{Nonaka2021}Nonaka CKV, Franco MM, Gr\"af T, de Lorenzo Barcia CA, de \'Avila Mendonca RN, de Sousa KAF, Neiva LMC, Fosenca V, Mendes AVA, de Aguiar RS, Giovanetti M, de Freitas Souza BS. 2021. Genomic Evidence of SARS-CoV-2 Reinfection Involving E484K Spike Mutation, Brazil. \textit{Emerg Infect Dis} \textbf{27}(5):1522--1524.

\bibitem{Mahajan2021}Mahajan NN, Gajbhiye RK, Lokhande PD, Bahirat S, Modi D, Mathe AM, Bharmal R, Rathi S, Mohite SC, Tilve A. 2021. Clinical Presentation of Cases with SARS-CoV-2 Reinfection/ Reactivation. \textit{J Assoc Physicians India} \textbf{69}(1):16--18.

\bibitem{Garvey2021}Garvey MI, Casey AL, Wilkinson MAC, Ratcliffe L, McMurray C, Stockton J, Holden E, Osman H, Loman NJ. 2021. Details of SARS-CoV-2 reinfections at a major UK tertiary centre. \textit{J Infect} \textbf{82}(6):e29--e30.

\bibitem{Harrington2021}Harrington D, Kele B, Pereira S, Couto-Parada X, Riddell A, Forbes S, Dobbie H, Cutino-Moguel T. 2021. Confirmed Reinfection with SARS-CoV-2 Variant VOC-202012/01. \textit{Clin Infect Dis} ciab014

\bibitem{Zucman2021}Zucman N, Uhel F, Descamps D, Roux D, Ricard JD. 2021. Severe reinfection with South African SARS-CoV-2 variant 501Y.V2: A case report. \textit{Clin Infect Dis} ciab129

\bibitem{Ramirez2021}Ram\'irez JD, Mu\~noz M, Ballesteros N, Pati\~no LH, Casta\~neda S, Rinc\'on CA, Mendez C, Oliveros C, Perez J, M\'arquez EK, Ortiz FLS, Correa-C\'ardenas CA, Duque MC, Paniz-Mondolfi A. 2021. Phylogenomic Evidence of Reinfection and Persistence of SARS-CoV-2: First Report from Colombia. \textit{Vaccines (Basel)} \textbf{9}(3):282.

\bibitem{VanElslande2021}Van Elslande J, Vermeersch P, Vandervoort K, Wawina-Bokalanga T, Vanmechelen B, Wollants E, Laenen L, André E, Van Ranst M, Lagrou K, Maes P. 2021. Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection by a Phylogenetically Distinct Strain. \textit{Clin Infect Dis} \textbf{73}(2):354--356.

\bibitem{Tomassini2021}Tomassini S, Kotecha D, Bird PW, Folwell A, Biju S, Tang JW. 2021. Setting the criteria for SARS-CoV-2 reinfection - six possible cases. \textit{J Infect} \textbf{82}(2):282--327. 

\bibitem{Hoang2020}Hoang VT, Dao TL, Gautret P. 2020. Recurrence of positive SARS-CoV-2 in patients recovered from COVID-19. \textit{J Med Virol} \textbf{92}(11):2366--2367.

\bibitem{Bongiovanni2021}Bongiovanni M. 2021. COVID-19 reinfection in a healthcare worker. \textit{J Med Virol} \textbf{93}(7):4058--4059.

\bibitem{Salzer2021}Salzer HJF, Neub\"ock M, Heldt S, Haug I, Paar C, Lamprecht B. 2021. Emerging COVID-19 reinfection four months after primary SARS-CoV-2 infection. \textit{Wien Med Wochenschr} 1--3. doi: 10.1007/s10354-021-00813-1

\bibitem{Sicsic2021}Sicsic I Jr, Chacon AR, Zaw M, Ascher K, Abreu A, Chediak A. 2021. A case of SARS-CoV-2 reinfection in a patient with obstructive sleep apnea managed with telemedicine. \textit{BMJ Case Rep} \textbf{14}(2):e240496

\bibitem{Salcin2021}Salcin S, Fontem F. 2021. Recurrent SARS-CoV-2 infection resulting in acute respiratory distress syndrome and development of pulmonary hypertension: A case report. \textit{Respir Med Case Rep} \textbf{33}:101314.

\bibitem{Selhorst2020}Selhorst P, Van Ierssel S, Michiels J, Mariën J, Bartholomeeusen K, Dirinck E, Vandamme S, Jansens H, Ari\"en KK. 2020. Symptomatic SARS-CoV-2 reinfection of a health care worker in a Belgian nosocomial outbreak despite primary neutralizing antibody response. \textit{Clin Infect Dis} ciaa1850.

\bibitem{Scarpati2021}Scarpati G, Piazza O, Pagliano P, Rizzo F. 2021. COVID-19: a confirmed case of reinfection in a nurse. \textit{BMJ Case Rep} \textbf{14}(7):e244507

\bibitem{Garg2021}Garg J, Agarwal J, Das A, Sen M. 2021. Recurrent COVID-19 infection in a health care worker: a case report. \textit{J Med Case Rep} \textbf{15}(1):363

\bibitem{Goes2021}Goes LR, Siqueira JD, Garrido MM, Alves BM, Pereira ACPM, Cicala C, Arthos J, Viola JPB, Soares MA; INCA COVID-19 Task Force. 2021. New infections by SARS-CoV-2 variants of concern after natural infections and post-vaccination in Rio de Janeiro, Brazil. \textit{Infect Genet Evol} \textbf{94}:104998

\bibitem{Ahmadian2021}Ahmadian S, Fathizadeh H, Shabestari Khiabani S, Asgharzadeh M, Kafil HS. 2021. COVID-19 reinfection in a healthcare worker after exposure with high dose of virus: A case report. \textit{Clin Case Rep} \textbf{9}(6):e04257.

\bibitem{Amorim2021}Amorim MR, Souza WM, Barros ACG Jr, Toledo-Teixeira DA, Dos-Santos KB, Simeoni CL, Parise PL, Vieira A, Forato J, Claro IM, Mofatto LS, Barbosa PP, Brunetti NS, Franca ESS, Pedroso GA, Carvalho BFN, Zaccariotto TR, Krywacz KCS, Vieira AS, Mori MA, Farias AS, Pavan MHP, Bachur LF, Cardoso LGO, Spilki FR, Sabino EC, Faria NR, Santos MNN, Angerami R, Leme PAF, Schreiber A, Moretti ML, Granja F, Proenca-Modena JL. 2021. Respiratory Viral Shedding in Healthcare Workers Reinfected with SARS-CoV-2, Brazil, 2020. \textit{Emerg Infect Dis} \textbf{27}(6):1737--1740.

\bibitem{Bongiovanni2021a}Bongiovanni M, Marra AM, Bini F, Bodini BD, Carlo DD, Giuliani G. 2021. COVID-19 reinfection in healthcare workers: A case series. \textit{J Infect} \textbf{82}(6):e4--e5.

\bibitem{SilvaMSD2020}Silva MSD, Demoliner M, Hansen AW, Gularte JS, Silveira F, Heldt FH, Filippi M, Pereira VMAG, Silva FPD, Mallmann L, Fink P, Silva LLD, Weber MN, Almeida PR, Fleck JD, Spilki FR. 2021. Early detection of SARS-CoV-2 P.1 variant in Southern Brazil and reinfection of the same patient by P.2. \textit{Rev Inst Med Trop Sao Paulo} \textbf{63}:e58
\bibitem{Bonifacio2020}Bonif\'acio LP, Pereira APS, Ara\'ujo DCAE, Balb\~ao VDMP, Fonseca BALD, Passos ADC, Bellissimo-Rodrigues F. 2020. Are SARS-CoV-2 reinfection and Covid-19 recurrence possible? a case report from Brazil. \textit{Rev Soc Bras Med Trop} \textbf{53}:e20200619

\bibitem{YuALF2021}Yu ALF, Liphaus BL, Ferreira PM, Tanamachi AT, Masuda ET, Trevisan CM, Lucas PCC, Bugno A, Carvalhanas TRMP. 2021. SARS-CoV-2 reinfection: report of two cases in Southeast Brazil. \textit{Rev Inst Med Trop Sao Paulo} \textbf{63}:e50.

\bibitem{Romano2021}Romano CM, Felix AC, Paula AV, Jesus JG, Andrade PS, Cândido D, Oliveira FM, Ribeiro AC, Silva FCD, Inemami M, Costa AA, Leal COD, Figueiredo WM, Pannuti CS, Souza WM, Faria NR, Sabino EC. 2021. SARS-CoV-2 reinfection caused by the P.1 lineage in Araraquara city, Sao Paulo State, Brazil. \textit{Rev Inst Med Trop Sao Paulo} \textbf{63}:e36.

\bibitem{West2021}West J, Everden S, Nikitas N. 2021. A case of COVID-19 reinfection in the UK. \textit{Clin Med (Lond)} \textbf{21}(1):e52--e53.

\bibitem{Sharma2020}Sharma R, Sardar S, Mohammad Arshad A, Ata F, Zara S, Munir W. 2020. A Patient with Asymptomatic SARS-CoV-2 Infection Who Presented 86 Days Later with COVID-19 Pneumonia Possibly Due to Reinfection with SARS-CoV-2. \textit{Am J Case Rep} \textbf{21}:e927154

\bibitem{Ozaras2020}Ozaras R, Ozdogru I, Yilmaz AA. 2020. Coronavirus disease 2019 re-infection: first report from Turkey. \textit{New Microbes New Infect} \textbf{38}:100774.

\bibitem{Colson2021}Colson P, Finaud M, Levy N, Lagier JC, Raoult D. 2021. Evidence of SARS-CoV-2 re-infection with a different genotype. \textit{J Infect} \textbf{82}(4):84--123.

\bibitem{Selvaraj2020}Selvaraj V, Herman K, Dapaah-Afriyie K. 2020. Severe, Symptomatic Reinfection in a Patient with COVID-19. \textit{R I Med J (2013)} \textbf{103}(10):24--26.

\bibitem{AlFehaidi2021}AlFehaidi A, Ahmad SA, Hamed E. 2021. SARS-CoV-2 re-infection: a case report from Qatar. \textit{J Infect} \textbf{82}(3):414--451.

\bibitem{deBrito2020}de Brito CAA, Lima PMA, de Brito MCM, de Oliveira DB. 2020. Second Episode of COVID-19 in Health Professionals: Report of Two Cases. \textit{Int Med Case Rep J} \textbf{13}:471-475

\bibitem{Tillett2021}Tillett RL, Sevinsky JR, Hartley PD, Kerwin H, Crawford N, Gorzalski A, Laverdure C, Verma SC, Rossetto CC, Jackson D, Farrell MJ, Van Hooser S, Pandori M. 2021. Genomic evidence for reinfection with SARS-CoV-2: a case study. \textit{Lancet Infect Dis} \textbf{21}(1):52--58.

\bibitem{MulderM2020}Mulder M, van der Vegt DSJM, Oude Munnink BB, GeurtsvanKessel CH, van de Bovenkamp J, Sikkema RS, Jacobs EMG, Koopmans MPG, Wegdam-Blans MCA. 2020. Reinfection of SARS-CoV-2 in an immunocompromised patient: a case report. \textit{Clin Infect Dis} ciaa1538. 

\bibitem{Hanif2020}Hanif M, Haider MA, Ali MJ, Naz S, Sundas F. 2020. Reinfection of COVID-19 in Pakistan: A First Case Report. \textit{Cureus} \textbf{12}(10):e11176.

\bibitem{Ferrante2021}Ferrante L, Livas S, Steinmetz WA, Almeida ACL, Le\~ao J, Vass\~ao RC, Tupinamb\'as U, Fearnside PM, Duczmal LH. 2021. The First Case of Immunity Loss and SARS-CoV-2 Reinfection by the Same Virus Lineage in Amazonia. \textit{J Racial Ethn Health Disparities} \textbf{8}(4):821--823

\bibitem{Arteaga-Livias20201}Arteaga-Livias K, Panduro-Correa V, Pinzas-Acosta K, Perez-Abad L, Pecho-Silva S, Espinoza-S\'anchez F, D\'amaso-Mata B, Rodriguez-Morales AJ. 2021. COVID-19 reinfection? A suspected case in a Peruvian patient. \textit{Travel Med Infect Dis} \textbf{39}:101947

\bibitem{Novoa2021}Novoa W, Miller H, Mattar S, Faccini-Mart\'inez ÁA, Rivero R, Serrano-Coll H. 2021. A first probable case of SARS-CoV-2 reinfection in Colombia. \textit{Ann Clin Microbiol Antimicrob} \textbf{20}(1):7

\bibitem{Alzedam2021}Alzedam A, Bengblya AM, Zeglam MJ, Benmassoud ET, Bennji SM. 2021. A case of COVID-19 re-infection in Libya. \textit{Afr J Thorac Crit Care Med} \textbf{27}(2):10.7196/AJTCCM.2021.v27i2.131

\bibitem{Camargo2021}Camargo CH, Goncalves CR, Pagnoca EVRG, Campos KR, Montanha JOM, Flores MNP, Soares MMCN, Binhardi FMT, Ferreira PM, Yu ALF, Carvalhanas TRMP, Abbud A, Bugno A, Sacchi CT. 2021. SARS-CoV-2 reinfection in a healthcare professional in inner Sao Paulo during the first wave of COVID-19 in Brazil. \textit{Diagn Microbiol Infect Dis} \textbf{101}(4):115516

\bibitem{DiazY2021}D\'iaz Y, Ortiz A, Weeden A, Castillo D, Gonz\'alez C, Moreno B, Mart\'inez-Montero M, Castillo M, Vasquez G, Sáenz L, Franco D, Pitti Y, Chavarria O, Gondola J, Moreno AM, \'Abrego L, Beltr\'an D, Guerra I, Chang J, Chaverra Z, Guerrero I, Valoy A, Gait\'an M, Ara\'uz D, Mor\'an E, Chen-Germ\'an M, Valdespino E, Rodr\'iguez R, Corrales R, Chen-Cama\~no R, Pascale JM, Mart\'inez AA, L\'opez-Verg\'es S; Gorgas COVID19 Team. 2021. SARS-CoV-2 reinfection with a virus harboring mutation in the Spike and the Nucleocapsid proteins in Panama. \textit{Int J Infect Dis} \textbf{108}:588--591.

\bibitem{Aguilar-Shea2021}Aguilar-Shea AL, Guti\'errez-Mart\'in-Arroyo J, Vacas-C\'ordoba M, Gallardo-Mayo C. 2021. Reinfection by SARS-CoV-2: The first one in a family reported in Spain. \textit{Med Clin (Barc)} S0025-7753(21)00250-5

\bibitem{Rodriguez2021}Rodr\'iguez-Espinosa D, Broseta Monz\'o JJ, Casals Q, Pi\~neiro GJ, Rodas L, Vera M, Maduell F. 2021. Fatal SARS-CoV-2 reinfection in an immunosuppressed patient on hemodialysis. \textit{J Nephrol} \textbf{34}(4):1041--1043.

\bibitem{Sanyang2021}Sanyang B, Kanteh A, Usuf E, Nadjm B, Jarju S, Bah A, Bojang A, Grey-Johnson M, Jones JC, Gai A, Sarr C, Sillah F, Wariri O, Oko F, Cerami C, Forrest K, Sey AP, Jallow H, Nwakanma D, Sesay AK, D'Alessandro U, Roca A. 2021. COVID-19 reinfections in The Gambia by phylogenetically distinct SARS-CoV-2 variants-first two confirmed events in west Africa. \textit{Lancet Glob Health} \textbf{9}(7):e905--e907

\bibitem{Loconsole2021}Loconsole D, Sallustio A, Accogli M, Centrone F, Casulli D, Madaro A, Tedeschi E, Parisi A, Chironna M. 2021. Symptomatic SARS-CoV-2 Reinfection in a Healthy Healthcare Worker in Italy Confirmed by Whole-Genome Sequencing. \textit{Viruses} \textbf{13}(5):899

\bibitem{Garduno-Orbe2021}Gardu\~no-Orbe B, S\'anchez-Rebolledo JM, Cort\'es-Rafael M, Garc\'ia-Jim\'enez Y, Perez-Ortiz M, Mendiola-Pastrana IR, L\'opez-Ortiz E, L\'opez-Ortiz G. 2021. SARS-CoV-2 Reinfection among Healthcare Workers in Mexico: Case Report and Literature Review. \textit{Medicina (Kaunas)} \textbf{57}(5):442

\bibitem{Vora2021}Vora T, Vora P, Vora F, Sharma K, Desai HD. 2021. Symptomatic reinfection with COVID-19: A first from Western India. \textit{J Family Med Prim Care} \textbf{10}(3):1496--1498.

\bibitem{Sanchez2021}S\'anchez Moll\'a M, de Gregorio Bernardo C, Ibarra Rizo M, Soriano A. 2021. [Reinfection by SARS-CoV-2 in a socio-sanitary residence. Description of the outbreak]. \textit{Aten Primaria} \textbf{53}(8):102100.

\bibitem{Fageeh2021}Fageeh H, Alshehri A, Fageeh H, Bizzoca ME, Lo Muzio L, Quadri MFA. 2021. Re-infection of SARS-CoV-2: A case in a young dental healthcare worker. \textit{J Infect Public Health} \textbf{14}(6):685--688.

\bibitem{Novazzi2021}Novazzi F, Baj A, Genoni A, Spezia PG, Colombo A, Cassani G, Zago C, Pasciuta R, Della Gasperina D, Ageno W, Severgnini P, Dentali F, Focosi D, Maggi F. 2021. SARS-CoV-2 B.1.1.7 reinfection after previous COVID-19 in two immunocompetent Italian patients. \textit{J Med Virol} \textbf{93}(9):5648--5649.

\bibitem{Letizia2021}Letizia AG, Smith DR, Ge Y, Ramos I, Sealfon RSG, Goforth C, Gonzalez-Reiche AS, Vangeti S, Weir DL, Alshammary H, Chen HW, George MC, Soares-Schanoski A, Lizewski RA, Lizewski SE, Marayag J, Miller CM, Nunez E, Porter CK, Ana ES, Schilling M, Sugiharto VA, Sun P, Termini M, van de Guchte A, Troyanskaya OG, van Bakel H, Sealfon SC. 2021. Viable virus shedding during SARS-CoV-2 reinfection. \textit{Lancet Respir Med} \textbf{9}(7):e56--e57

\bibitem{Staub2021}Staub T, Arendt V, Lasso de la Vega EC, Braquet P, Michaux C, Kohnen M, Tsobo C, Abdelrahman T, Wienecke-Baldacchino A, Francois JH. 2021. Case series of four re-infections with a SARS-CoV-2 B.1.351 variant, Luxembourg, February 2021. \textit{Euro Surveill} \textbf{26}(18):2100423. 

\bibitem{Brehm2021}Brehm TT, Pfefferle S, von Possel R, Kobbe R, N\"orz D, Schmiedel S, Grundhoff A, Olearo F, Emmerich P, Robitaille A, G\"unther T, Braun P, Andersen G, Knobloch JK, Addo MM, Lohse AW, Aepfelbacher M, Fischer N, Schulze Zur Wiesch J, L\"utgehetmann M. 2021. SARS-CoV-2 Reinfection in a Healthcare Worker Despite the Presence of Detectable Neutralizing Antibodies. \textit{Viruses} \textbf{13}(4):661.

\bibitem{Konstantinou2021}Konstantinou F, Skrapari I, Bareta E, Bakogiannis N, Papadopoulou AM, Bakoyiannis C. 2021. A Case of SARS-CoV-2 Clinical Relapse after 4 Negative RT-PCR Tests in Greece: Recurrence or Reinfection? \textit{Clin Med Insights Case Rep} \textbf{14}:11795476211009813.

\bibitem{Shoar2021}Shoar S, Khavandi S, Tabibzadeh E, Khavandi S, Naderan M, Shoar N. 2021. Recurrent coronavirus diseases 19 (COVID-19): A different presentation from the first episode. \textit{Clin Case Rep} \textbf{9}(4):2149--2152.

\bibitem{Rani2021}Rani PR, Imran M, Lakshmi JV, Jolly B, Jain A, Surekha A, Senthivel V, Chandrasekhar P, Divakar MK, Srinivasulu D, Bhoyar RC, Vanaja PR, Scaria V, Sivasubbu S. 2021. Symptomatic reinfection of SARS-CoV-2 with spike protein variant N440K associated with immune escape. \textit{J Med Virol} \textbf{93}(7):4163--4165.

\bibitem{Vancsa2021}V\'ancsa S, Dembrovszky F, Farkas N, Szak\'o L, Teutsch B, Bunduc S, Nagy R, P\'arniczky A, Er\'oss B, P\'eterfi Z, Hegyi P. 2021. Repeated SARS-CoV-2 Positivity: Analysis of 123 Cases. \textit{Viruses} \textbf{13}(3):512

\bibitem{Das2021}Das P, Satter SM, Ross AG, Abdullah Z, Nazneen A, Sultana R, Rimi NA, Chowdhury K, Alam R, Parveen S, Rahman MM, Hossain ME, Rahman MZ, Mazumder R, Abdullah A, Rahman M, Banu S, Ahmed T, Clemens JD, Rahman M. 2021. A Case Series Describing the Recurrence of COVID-19 in Patients Who Recovered from Initial Illness in Bangladesh. \textit{Trop Med Infect Dis} \textbf{6}(2):41.

\bibitem{Fintelman-Rodrigues2021}Fintelman-Rodrigues N, da Silva APD, Dos Santos MC, Saraiva FB, Ferreira MA, Gesto J, Rodrigues DAS, Vale AM, de Azevedo IG, Soares VC, Jiang H, Tan H, Tschoeke DA, Sacramento CQ, Bozza FA, Morel CM, Bozza PT, Souza TML. 2021. Genetic Evidence and Host Immune Response in Persons Reinfected with SARS-CoV-2, Brazil. \textit{Emerg Infect Dis} \textbf{27}(5):1446--1453.

\bibitem{Teka2021}Teka IA, BenHasan MH, Alkershini AA, Alatresh OK, Abulifa TA, Lembagga HA, Alhudiri IM, Elzagheid A. 2021. Reinfection with SARS-CoV-2: A case report from Libya. \textit{Travel Med Infect Dis} \textbf{41}:102040

\bibitem{RoyS2021}Roy S. 2021. COVID-19 Reinfection in the Face of a Detectable Antibody Titer. \textit{Cureus} \textbf{13}(3):e14033.

\bibitem{Fernandes2021}Fernandes AC, Figueiredo R. 2021. SARS-CoV-2 reinfection: a case report from Portugal. \textit{Rev Soc Bras Med Trop} \textbf{54}:e0002-2021.

\bibitem{Ul-Haq2020}Ul-Haq Z, Khan A, Fazid S, Noor F, Yousafzai YM, Sherin A. 2020. First documented reinfection of SARS-COV-2 in second wave from Pakistan. \textit{J Ayub Med Coll Abbottabad} \textbf{32}(Suppl 1)(4):S704-S705.

\bibitem{Krishna2021}Krishna VN, Ahmad M, Overton ET, Jain G. 2021. Recurrent COVID-19 in Hemodialysis: A Case Report of 2 Possible Reinfections. \textit{Kidney Med} \textbf{3}(3):447--450.

\bibitem{LeungHossain2021}Leung S, Hossain N. 2021. Recurrence and Recovery of COVID-19 in an Older Adult Patient with Multiple Comorbidities: A Case Report. \textit{Gerontology} \textbf{67}(4):445--448. 

\bibitem{Salehi-Vaziri2021}Salehi-Vaziri M, Omrani MD, Pouriayevali MH, Fotouhi F, Banifazl M, Farahmand B, Sadat Larijani M, Ahmadi Z, Fereydouni Z, Tavakoli M, Jalali T, Ramezani A. 2021. SARS-CoV-2 presented moderately during two episodes of the infection with lack of antibody responses. \textit{Virus Res} \textbf{299}:198421.

\bibitem{Salehi-Vaziri2021b}Salehi-Vaziri M, Jalali T, Farahmand B, Fotouhi F, Banifazl M, Pouriayevali MH, Sadat Larijani M, Afzali N, Ramezani A. 2021. Clinical characteristics of SARS-CoV-2 by re-infection vs. reactivation: a case series from Iran. \textit{Eur J Clin Microbiol Infect Dis} \textbf{40}(8):1713--1719.

\bibitem{Yadav2021}Yadav SP, Wadhwa T, Thakkar D, Kapoor R, Rastogi N, Sarma S. 2021. COVID-19 reinfection in two children with cancer. \textit{Pediatr Hematol Oncol} \textbf{38}(4):403--405.

\bibitem{Cavanaugh2021}Cavanaugh AM, Thoroughman D, Miranda H, Spicer K. 2021. Suspected Recurrent SARS-CoV-2 Infections Among Residents of a Skilled Nursing Facility During a Second COVID-19 Outbreak - Kentucky, July-November 2020. \textit{MMWR Morb Mortal Wkly Rep} \textbf{70}(8):273--277.

\bibitem{Vetter2021}Vetter P, Cordey S, Schibler M, Vieux L, Despres L, Laubscher F, Andrey DO, Martischang R, Harbarth S, Cuvelier C, Bekliz M, Eckerle I, Siegrist CA, Didierlaurent AM, Eberhardt CS, Meyer B, Kaiser L; Geneva Center for Emerging Viral Diseases. 2021. Clinical, virologic and immunologic features of a mild case of SARS-CoV-2 reinfection. \textit{Clin Microbiol Infect} \textbf{27}(5):791.e1--4.

\bibitem{LeeJT2021}Lee JT, Hesse EM, Paulin HN, Datta D, Katz LS, Talwar A, Chang G, Galang RR, Harcourt JL, Tamin A, Thornburg NJ, Wong KK, Stevens V, Kim K, Tong S, Zhou B, Queen K, Drobeniuc J, Folster JM, Sexton DJ, Ramachandran S, Browne H, Iskander J, Mitruka K. 2021. Clinical and Laboratory Findings in Patients with Potential SARS-CoV-2 Reinfection, May-July 2020. \textit{Clin Infect Dis} ciab148.

\bibitem{Kulkarni2021}Kulkarni O, Narreddy S, Zaveri L, Kalal IG, Tallapaka KB, Sowpati DT. 2021. Evidence of SARS-CoV-2 reinfection without mutations in Spike protein. \textit{Clin Infect Dis} ciab136.

\bibitem{AdrielleDosSantos2021}Adrielle Dos Santos L, Filho PGG, Silva AMF, Santos JVG, Santos DS, Aquino MM, de Jesus RM, Almeida MLD, da Silva JS, Altmann DM, Boyton RJ, Alves Dos Santos C, Santos CNO, Alves JC, Santos IL, Magalhães LS, Belitardo EMMA, Rocha DJPG, Almeida JPP, Pacheco LGC, Aguiar ERGR, Campos GS, Sardi SI, Carvalho RH, de Jesus AR, Rezende KF, de Almeida RP. 2021. Recurrent COVID-19 including evidence of reinfection and enhanced severity in thirty Brazilian healthcare workers. \textit{J Infect} \textbf{82}(3):399--406. 

\bibitem{Inada2021}Inada M, Ishikane M, Terada M, Matsunaga A, Maeda K, Tsuchiya K, Miura K, Sairenji Y, Kinoshita N, Ujiie M, Kutsuna S, Ishizaka Y, Mitsuya H, Ohmagari N. 2021. Asymptomatic COVID-19 re-infection in a Japanese male by elevated half-maximal inhibitory concentration (IC$_50$) of neutralizing antibodies. \textit{J Infect Chemother} \textbf{27}(7):1063--1067.

\bibitem{Fonseca2021}Fonseca V, de Jesus R, Adelino T, Reis AB, de Souza BB, Ribeiro AA, Guimar\~aes NR, Livorati MTFP, Neto DFL, Kato RB, Portela LMO, Dutra LH, Freitas C, de Abreu AL, Filizzola ERM, de Medeiros AC, Iani FCM, Carvalho G, Lourenço J, de Oliveira T, Alcantara LCJ, Giovanetti M. 2021. Genomic evidence of SARS-CoV-2 reinfection case with the emerging B.1.2 variant in Brazil. \textit{J Infect} \textbf{83}(2):237--279.

\bibitem{ZhouX2021}Zhou X, Zhou YN, Ali A, Liang C, Ye Z, Chen X, Zhang Q, Deng L, Sun X, Zhang Q, Luo J, Li W, Zhou K, Cao S, Zhang X, Li XD, Zhang XE, Cui Z, Men D. 2021. Case Report: A Re-Positive Case of SARS-CoV-2 Associated With Glaucoma. \textit{Front Immunol} \textbf{12}:70129

\bibitem{Massachi2021}Massachi J, Donohue KC, Kelly JD. 2021. Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection Cases Corroborated by Sequencing. \textit{Am J Trop Med Hyg} tpmd210365.

\bibitem{Massanella2021}Massanella M, Martin-Urda A, Mateu L, Mar\'in T, Aldas I, Riveira-Mu\~noz E, Kipelainen A, Jim\'enez-Moyano E, Rodriguez de la Concepción ML, Avila-Nieto C, Trinit\'e B, Pradenas E, Rodon J, Marfil S, Parera M, Carrillo J, Blanco J, Prado JG, Ballana E, Vergara-Alert J, Segal\'es J, Noguera-Julian M, Masabeu \`A, Clotet B, Toda MR, Paredes R. 2021. Critical Presentation of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection: A Case Report. \textit{Open Forum Infect Dis} \textbf{8}(7):ofab329

\bibitem{Romera2021}Romera I, N\'u\~nez K, Calizaya M, Baeza I, Molina R, Morillas J. 2021. SARS-CoV-2 reinfection. \textit{Med Intensiva (Engl Ed)} \textbf{45}(6):375--376.

\bibitem{Alshukairi2021}Alshukairi AN, El-Kafrawy SA, Dada A, Yasir M, Yamani AH, Saeedi MF, Aljohaney A, AlJohani NI, Bahaudden HA, Alam I, Gojobori T, Radovanovic A, Alandijany TA, Othman NA, Alsubhi TL, Hassan AM, Tolah AM, Al-Tawfiq JA, Zumla A, Azhar EI. 2021. Re-infection with a different SARS-CoV-2 clade and prolonged viral shedding in a hematopoietic stem cell transplantation patient. \textit{Int J Infect Dis} \textbf{110}:267--271.

\bibitem{Bader2021}Bader N, Khattab M, Farah F. 2021. Severe reinfection with severe acute respiratory syndrome coronavirus 2 in a nursing home resident: a case report. \textit{J Med Case Rep} \textbf{15}(1):392.

\bibitem{Awada2021}Awada H, Nassereldine H, Hajj Ali A. 2021. Severe acute respiratory syndrome coronavirus 2 reinfection in a coronavirus disease 2019 recovered young adult: a case report. \textit{J Med Case Rep} \textbf{15}(1):382

\bibitem{Zanferrari2021}Zanferrari C, Fanucchi S, Sollazzo MT, Ranieri M, Volterra D, Valvassori L. 2021. Focal Cerebral Arteriopathy in a Young Adult Following SARS-CoV2 Reinfection. \textit{J Stroke Cerebrovasc Dis} \textbf{30}(9):105944.

\bibitem{ZhangN2021}Zhang N, Chen X, Jia W, Jin T, Xiao S, Chen W, Hang J, Ou C, Lei H, Qian H, Su B, Li J, Liu D, Zhang W, Xue P, Liu J, Weschler LB, Xie J, Li Y, Kang M. 2021. Evidence for lack of transmission by close contact and surface touch in a restaurant outbreak of COVID-19. \textit{J Infect} \textbf{83}(2):207--216.

\bibitem{VitaleJ2021}Vitale J, Mumoli N, Clerici P, De Paschale M, Evangelista I, Cei M, Mazzone A. 2021. Assessment of SARS-CoV-2 Reinfection 1 Year After Primary Infection in a Population in Lombardy, Italy. \textit{JAMA Intern Med} e212959

\bibitem{Babiker200}Babiker A, Marvil CE, Waggoner JJ, Collins MH, Piantadosi A. 2020. The importance and challenges of identifying SARS-CoV-2 reinfections. \textit{J Clin Microbiol} \textbf{59}(4):e02769--20.

\bibitem{Boyton2021}Boyton RJ, Altmann DM. 2021. Risk of SARS-CoV-2 reinfection after natural infection. \textit{Lancet} \textbf{397}(10280):1161--1163.

\bibitem{Hansen2021}Hansen CH, Michlmayr D, Gubbels SM, Molbak K, Ethelberg S. 2021. Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study. \textit{Lancet} \textbf{397}(10280):1204--1212.

\bibitem{Tegally2021}Tegally H, Wilkinson E, Giovanetti M, Iranzadeh A, Fonseca V, Giandhari J, Doolabh D, Pillay S, San EJ, Msomi N, Mlisana K, von Gottberg A, Walaza S, Allam M, Ismail A, Mohale T, Glass AJ, Engelbrecht S, Van Zyl G, Preiser W, Petruccione F, Sigal A, Hardie D, Marais G, Hsiao NY, Korsman S, Davies MA, Tyers L, Mudau I, York D, Maslo C, Goedhals D, Abrahams S, Laguda-Akingba O, Alisoltani-Dehkordi A, Godzik A, Wibmer CK, Sewell BT, Lourenço J, Alcantara LCJ, Kosakovsky Pond SL, Weaver S, Martin D, Lessells RJ, Bhiman JN, Williamson C, de Oliveira T. 2021. Detection of a SARS-CoV-2 variant of concern in South Africa. \textit{Nature} \textbf{592}(7854):438--443.

\bibitem{Gousseff2020}Gousseff M, Penot P, Gallay L, Batisse D, Benech N, Bouiller K, Collarino R, Conrad A, Slama D, Joseph C, Lemaignen A, Lescure FX, Levy B, Mahevas M, Pozzetto B, Vignier N, Wyplosz B, Salmon D, Goehringer F, Botelho-Nevers E; in behalf of the COCOREC study group. 2020. Clinical recurrences of COVID-19 symptoms after recovery: Viral relapse, reinfection or inflammatory rebound? \textit{J Infect} \textbf{81}(5):816--846.

\bibitem{IwasakiA2020}Iwasaki A. 2020. What reinfections mean for COVID-19. \textit{Lancet Infect Dis} \textbf{2}(20):19--20.

\bibitem{LeidiA2021}Leidi A, Koegler F, Dumont R, Dubos R, Zaballa ME, Piumatti G, Coen M, Berner A, Darbellay Farhoumand P, Vetter P, Vuilleumier N, Kaiser L, Courvoisier D, Azman AS, Guessous I, Stringhini S; SEROCoV-POP study group. 2021. Risk of reinfection after seroconversion to SARS-CoV-2: A population-based propensity-score matched cohort study. \textit{Clin Infect Dis} ciab495

\bibitem{HallVJ2021}Hall VJ, Foulkes S, Charlett A, Atti A, Monk EJM, Simmons R, Wellington E, Cole MJ, Saei A, Oguti B, Munro K, Wallace S, Kirwan PD, Shrotri M, Vusirikala A, Rokadiya S, Kall M, Zambon M, Ramsay M, Brooks T, Brown CS, Chand MA, Hopkins S; SIREN Study Group. 2021. SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN). \textit{Lancet} \textbf{397}(10283):1459--1469.

\bibitem{Abu-Raddad2020}Abu-Raddad LJ, Chemaitelly H, Malek JA, Ahmed AA, Mohamoud YA, Younuskunju S, Ayoub HH, Al Kanaani Z, Al Khal A, Al Kuwari E, Butt AA, Coyle P, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Rahim HFA, Yassine HM, Al Kuwari MG, Al Romaihi HE, Al-Thani MH, Bertollini R. 2020. Assessment of the risk of SARS-CoV-2 reinfection in an intense re-exposure setting. \textit{Clin Infect Dis} ciaa1846

\bibitem{Ghorbani2021}Ghorbani SS, Taherpour N, Bayat S, Ghajari H, Mohseni P, Hashemi Nazari SS. 2021. Epidemiologic characteristics of cases with re-infection, recurrence and hospital readmission due to COVID-19: a systematic review and meta-analysis. \textit{J Med Virol} doi: 10.1002/jmv.27281

\bibitem{Santiago-Espinosa2021}Santiago-Espinosa O, Prieto-Torres ME, Cabrera-Gayt\'an DA. 2021. Laboratory-confirmed SARS-CoV-2 reinfection in the population treated at social security. \textit{Respir Med Case Rep} \textbf{34}:101493.

\bibitem{Peghin2021}Peghin M, Bouza E, Fabris M, De Martino M, Palese A, Bontempo G, Graziano E, Gerussi V, Bressan V, Sartor A, Isola M, Tascini C, Curcio F. 2021. Low risk of reinfections and relation with serological response after recovery from the first wave of COVID-19. \textit{Eur J Clin Microbiol Infect Dis} 1--8.

\bibitem{Wilkins2021}Wilkins JT, Hirschhorn LR, Gray EL, Wallia A, Carnethon M, Zembower TR, Ho J, DeYoung BJ, Zhu A, Torvik LJR, Taiwo B, Evans CT. 2021. Serologic Status and SARS CoV-2 Infection over 6-Months of Follow-Up in Healthcare Workers in Chicago: A Cohort Study. \textit{Infect Control Hosp Epidemiol} 1--29.

\bibitem{AliAM2021}Ali AM, Ali KM, Fatah MH, Tawfeeq HM, Rostam HM. 2021. SARS-CoV-2 reinfection in patients negative for immunoglobulin G following recovery from COVID-19. \textit{New Microbes New Infect} \textbf{43}:100926.

\bibitem{Lawandi2021}Lawandi A, Warner S, Sun J, Demirkale CY, Danner RL, Klompas M, Gundlapalli A, Datta D, Harris AM, Morris SB, Natarajan P, Kadri SS. 2021. Suspected SARS-CoV-2 Reinfections: Incidence, Predictors, and Healthcare Use among Patients at 238 U.S. Healthcare Facilities, June 1, 2020- February 28, 2021. \textit{Clin Infect Dis} ciab671

\bibitem{Ringlander2021}Ringlander J, Olausson J, Nystr\"om K, H\"arnqvist T, Jakobsson HE, Lindh M. 2021. Recurrent and persistent infection with SARS-CoV-2 - epidemiological data and case reports from Western Sweden, 2020. Infect Dis (Lond). 1--8

\bibitem{Dobano2021}Doba\~no C, Ram\'irez-Morros A, Alonso S, Vidal-Alaball J, Ruiz-Olalla G, Vidal M, Rubio R, Cascant E, Parras D, Rodrigo Melero N, Serra P, Carolis C, Santamaria P, Forcada A, Mendioroz J, Aguilar R, Moncunill G, Ruiz-Comellas A. 2021. Persistence and baseline determinants of seropositivity and reinfection rates in health care workers up to 12.5 months after COVID-19. \textit{BMC Med} \textbf{19}(1):155. 

\bibitem{SanchesMontava2021}S\'anchez-Montalv\'a A, Fern\'andez-Naval C, Ant\'on A, Dur\`a X, Vimes A, Silgado A, Vel\'asquez-Orozco F, Espinosa-Pereiro J, Salvador F, Pumarola T, Almirante B, Esperalba J. 2021. Risk of SARS-CoV-2 Infection in Previously Infected and Non-Infected Cohorts of Health Workers at High Risk of Exposure. \textit{J Clin Med} \textbf{10}(9):1968. 

\bibitem{Lutrick2021}Lutrick K, Ellingson KD, Baccam Z, Rivers P, Beitel S, Parker J, Hollister J, Sun X, Gerald JK, Komatsu K, Kim E, LaFleur B, Grant L, Yoo YM, Kumar A, Mayo Lamberte J, Cowling BJ, Cobey S, Thornburg NJ, Meece JK, Kutty P, Nikolich-Zugich J, Thompson MG, Burgess JL. 2021. COVID-19 Infection, Reinfection, and Vaccine Effectiveness in a Prospective Cohort of Arizona Frontline/Essential Workers: The AZ HEROES Research Protocol. \textit{JMIR Res Protoc} doi: 10.2196/28925

\bibitem{Crellen2021}Crellen T, Pi L, Davis EL, Pollington TM, Lucas TCD, Ayabina D, Borlase A, Toor J, Prem K, Medley GF, Klepac P, D\'eirdre Hollingsworth T. 2021. Dynamics of SARS-CoV-2 with waning immunity in the UK population. \textit{Philos Trans R Soc Lond B Biol Sci} \textbf{376}(1829):20200274

\bibitem{Breathnach2021}Breathnach AS, Riley PA, Cotter MP, Houston AC, Habibi MS, Planche TD. 2021. Prior COVID-19 significantly reduces the risk of subsequent infection, but  reinfections are seen after eight months. \textit{J Infect} \textbf{82}(4):e11--e12. 

\bibitem{Breathnach2021b}Breathnach AS, Duncan CJA, Bouzidi KE, Hanrath AT, Payne BAI, Randell PA, Habibi MS, Riley PA, Planche TD, Busby JS, Sudhanva M, Pallett SJC, Kelleher WP. 2021. Prior COVID-19 protects against reinfection, even in the absence of detectable antibodies. \textit{J Infect} \textbf{83}(2):237--279.

\bibitem{OMurchu2021}O Murchu E, Byrne P, Carty PG, De Gascun C, Keogan M, O'Neill M, Harrington P, Ryan M. 2021. Quantifying the risk of SARS-CoV-2 reinfection over time. \textit{Rev Med Virol} e2260

\bibitem{Leidi2021}Leidi A, Koegler F, Dumont R, Dubos R, Zaballa ME, Piumatti G, Coen M, Berner A, Darbellay Farhoumand P, Vetter P, Vuilleumier N, Kaiser L, Courvoisier D, Azman AS, Guessous I, Stringhini S; SEROCoV-POP study group. 2021. Risk of reinfection after seroconversion to SARS-CoV-2: A population-based propensity-score matched cohort study. \textit{Clin Infect Dis} ciab495.

\bibitem{Iruretagoyena2021}Iruretagoyena M, Vial MR, Spencer-Sandino M, Gaete P, Peters A, Delgado I, Perez I, Calderon C, Porte L, Legarraga P, Anderson A, Aguilera X, Vial P, Weitzel T, Munita JM. 2021. Longitudinal assessment of SARS-CoV-2 IgG seroconversionamong front-line healthcare workers during the first wave of the Covid-19 pandemic at a tertiary-care hospital in Chile. \textit{BMC Infect Dis} \textbf{21}(1):478

\bibitem{Turnerjs2021}Turner JS, Kim W, Kalaidina E, Goss CW, Rauseo AM, Schmitz AJ, Hansen L, Haile A, Klebert MK, Pusic I, O'Halloran JA, Presti RM, Ellebedy AH. 2021. SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans. \textit{Nature} \textbf{595}(7867):421--425.

\bibitem{Qureshi2021}Qureshi AI, Baskett WI, Huang W, Lobanova I, Naqvi SH, Shyu CR. 2021. Re-infection with SARS-CoV-2 in Patients Undergoing Serial Laboratory Testing. \textit{Clin Infect Dis} ciab345

\bibitem{ZareF2021}Zare F, Teimouri M, Khosravi A, Rohani-Rasaf M, Chaman R, Hosseinzadeh A, Jamali Atergeleh H, Binesh E, Emamian MH. 2021. COVID-19 re-infection in Shahroud, Iran: a follow-up study. \textit{Epidemiol Infect} \textbf{149}:e159.

\bibitem{Fabianova2021}Fabi\'anov\'a K, Kyncl J, Vlckov\'a I, Jirincov\'a H, Ko\v{s}t\'alov\'a J, Lipt\'akov\'a M, Orl\'ikov\'a H, \v{S}ebestov\'a H, Limberkov\'a R, Mackov\'a B, Mal\'y M. 2021. COVID-19 reinfections. \textit{Epidemiol Mikrobiol Imunol} \textbf{70}(1):62--67.

\bibitem{Davido2021}Davido B, De Truchis P, Lawrence C, Annane D, Domart-Rancon M, Gault E, Saleh-Mghir A, Delarocque-Astagneau E, Gautier S. 2021. SARS-CoV-2 reinfections among hospital staff in the greater Paris area. \textit{J Travel Med} \textbf{28}(4):taab058.

\bibitem{Brouqui2021}Brouqui P, Colson P, Melenotte C, Houhamdi L, Bedotto M, Devaux C, Gautret P, Million M, Parola P, Stoupan D, La Scola B, Lagier JC, Raoult D. 2021. COVID-19 re-infection. \textit{Eur J Clin Invest} \textbf{51}(5):e13537

\bibitem{Dimeglio2021}Dimeglio C, Herin F, Miedoug\'e M, Martin-Blondel G, Soulat JM, Izopet J. 2021. Protection of healthcare workers against SARS-CoV-2 reinfection. \textit{Clin Infect Dis} ciab069.

\bibitem{Rennert2021}Rennert L, McMahan C. 2021. Risk of SARS-CoV-2 reinfection in a university student population. \textit{Clin Infect Dis} ciab454

\bibitem{RaddadLJ2021}Abu-Raddad LJ, Chemaitelly H, Coyle P, Malek JA, Ahmed AA, Mohamoud YA, Younuskunju S, Ayoub HH, Al Kanaani Z, Al Kuwari E, Butt AA, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Abdul Rahim HF, Nasrallah GK, Yassine HM, Al Kuwari MG, Al Romaihi HE, Al-Thani MH, Al Khal A, Bertollini R. 2021. SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95\% efficacy. \textit{EClinicalMedicine} \textbf{35}:100861

\bibitem{Hanrath2021}Hanrath AT, Payne BAI, Duncan CJA. 2021. Prior SARS-CoV-2 infection is associated with protection against symptomatic reinfection. \textit{J Infect} \textbf{82}(4):e29--e30.

\bibitem{Lumley2021}Lumley SF, O'Donnell D, Stoesser NE, Matthews PC, Howarth A, Hatch SB, Marsden BD, Cox S, James T, Warren F, Peck LJ, Ritter TG, de Toledo Z, Warren L, Axten D, Cornall RJ, Jones EY, Stuart DI, Screaton G, Ebner D, Hoosdally S, Chand M, Crook DW, O'Donnell AM, Conlon CP, Pouwels KB, Walker AS, Peto TEA, Hopkins S, Walker TM, Jeffery K, Eyre DW; Oxford University Hospitals Staff Testing Group. 2021. Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers. \textit{N Engl J Med} \textbf{384}(6):533--540.

\bibitem{Hamed2021}Hamed E, Sedeeq S, Alnuaimi AS, Syed M, ElHamid MA, Alemrayat B, Mukhtar A, AlFehaidi A, A/Qotba H. 2021. Rates of recurrent positive SARS-CoV-2 swab results among patients attending primary care in Qatar. \textit{J Infect} \textbf{82}(4):84--123.

\bibitem{Addetia2020}Addetia A, Crawford KHD, Dingens A, Zhu H, Roychoudhury P, Huang ML, Jerome KR, Bloom JD, Greninger AL. 2020. Neutralizing Antibodies Correlate with Protection from SARS-CoV-2 in Humans during a Fishery Vessel Outbreak with a High Attack Rate. \textit{J Clin Microbiol} \textbf{58}(11):e02107--20.

\bibitem{Mack2021}Mack CD, Tai C, Sikka R, Grad YH, Maragakis LL, Grubaugh ND, Anderson DJ, Ho D, Merson M, Samant RM, Fauver JR, Barrett J, Sims L, DiFiori J. 2021. SARS-CoV-2 Reinfection: A Case Series from a 12-Month Longitudinal Occupational Cohort. \textit{Clin Infect Dis} ciab738